Menopause and ageing in women with multiple sclerosis - Takeaways - MDSpire

Menopause and ageing in women with multiple sclerosis

  • By

  • Cecilia Smith Simonsen

  • Elisabeth Gulowsen Celius

  • June 9, 2026

  • 0 min

Share

  • 1

    Menopause does not appear to independently influence relapse activity or MRI-defined inflammation in women with multiple sclerosis.

  • 2

    Recent studies indicate menopause does not significantly affect Expanded Disability Status Scale progression when accounting for age.

  • 3

    Symptom burden often worsens during midlife due to hormonal changes, comorbidities, and ageing, complicating clinical management.

  • 4

    Menopausal hormone therapy may alleviate symptoms but its impact on multiple sclerosis disease progression remains uncertain.

  • 5

    Menopause should be viewed as part of broader biological ageing rather than a distinct inflection point in multiple sclerosis.

Original Source(s)

Menopause and ageing in women with multiple sclerosis

  • by Cecilia Smith Simonsen, Elisabeth Gulowsen Celius

  • June 9, 2026

Related Content

Stem cell-derived extracellular vesicles as immunomodulatory agents: targeting pathological crosstalk in systemic lupus erythematosus and multiple sclerosis

Patient Satisfaction in Relapsing-Remitting Multiple Sclerosis: Benefits of Home-Based Self-Administration of Subcutaneous Ofatumumab Compared to Other High-Efficacy Treatments

Global overview of multiple sclerosis care units: an international cross-sectional survey